首页|疏肝通降法方剂治疗胃食管反流病的临床疗效观察

疏肝通降法方剂治疗胃食管反流病的临床疗效观察

扫码查看
目的:明确疏肝通降法方剂对质子泵抑制剂(PPIs)规范化治疗后胃食管反流病(GERD)患者的维持治疗作用。方法:103例符合纳入和排除标准的GERD患者,按照就诊顺序随机分入治疗组(54例)和对照组(49例),分别接受疏肝通降法免煎剂+PPIs模拟剂、中药安慰剂+PPIs(泮托拉唑钠肠溶胶囊)治疗4周。对治疗前后患者的反流症状评分、匹斯堡睡眠质量评分(PSQI)、Zung焦虑自评量表(SAS)和抑郁自评量表(SDS)以及生活质量评分(SF-36)进行比较。结果:①与治疗前比较,治疗后治疗组和对照组反酸、烧心、反食或反胃、胸骨后疼痛4个症状评分及食管反流症状总评分均显著降低(P<0。05),但2组间比较差异无统计学意义(P>0。05)。②治疗后2组的PSQI评分与治疗前比较差异均无统计学意义(P>0。05),且2组间比较差异无统计学意义(P>0。05)。③治疗组和对照组治疗后的SAS和SDS评分与治疗前比较均有所降低,但差异无统计学意义(P>0。05),且组间比较差异亦无统计学意义(P>0。05)。④与治疗前比较,治疗组患者治疗后的心理职能、社会功能和总体健康3个维度的评分显著改善(P<0。05),但与对照组比较差异无统计学意义(P>0。05)。结论:疏肝通降法方剂可使GERD患者食管反流症状明显改善,其疗效与PPIs相当。疏肝通降法方剂可改善GERD患者生活质量,但对GERD患者睡眠质量和精神心理评分无显著影响。
The therapeutic effect of Shugan Tongjiang compound on patients with gastroesophageal reflux disease
Objective:To study the maintenance effect of the Shugan Tongjiang compound on gastro-esophage-al reflux disease(GERD)patients after standardized proton pump inhibitors(PPIs)treatment.Methods:A total of 103 GERD patients in compliance with the inclusion and exclusion criteria,were randomly divided into two groups according to the visiting orders,54 patients in the treatment group were treated with formula granule of Shugan Tongjiang compound plus PPIs Simulator,and 49 patients in placebo group were treated with placebo plus PPIs(® Pazolazole Sodium),all courses of treatment were 4 weeks.The scores of reflux symptoms,Pittsburgh sleep quality scale(PSQI),Zung self-rating anxiety and depression scale(SDS/SDS),and quality of life scale(SF-36)were compared before and after treatment.Results:Compared with baseline,the symptom scores of esophageal reflux symptoms,such as acid regurgitation,heartburn,food regurgitation,and retrosternal pain,and the total scores after 4 weeks of treatment,were significantly decreased in both groups(P<0.05),but there was no signif-icant differences between the two groups(P>0.05).There was no significant difference in PSQI between baseline and 4 weeks after treatment(P>0.05)in the two groups,and no significant differences(P>0.05)was found in SAS and SDS either,even if the scores were decreased from baseline after 4 weeks treatment in both groups,and no significant differences were found between the two groups(P>0.05).In SF-36,the scores of psychological function,social function and general health were significantly improved in the Shugan Tongjiang compound group at 4 weeks after treatment compared with baseline(P<0.05),but there were no significant differences between the two groups(P>0.05).Conclusion:The Shugan Tongjiang compound can improve esophageal reflux symp-toms in GERD patients,and its curative effect is equal to that of PPIs.Shugan Tongjiang compound can improve the quality of life in GERD patients,but no significant improvement was found in sleep quality and psychological conditions.

gastro-esophageal reflux diseaseShugan Tongjiang compoundsymptomspsychological condi-tionquality of life

白亦冰、张静、刘永、戚海龙、苏敏、魏仕兵

展开 >

北京市宣武中医医院脾胃病科(北京,100050)

胃食管反流病 疏肝通降法 症状 精神心理 生活质量

北京市科技计划首都特色基金

Z171100001017101

2024

中国中西医结合消化杂志
华中科技大学同济医学院,中国中西医结合学会消化系统疾病专业委员会,中华中医药学会脾胃病专业委员会

中国中西医结合消化杂志

CSTPCD
影响因子:1.363
ISSN:1671-038X
年,卷(期):2024.32(7)